Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

ByGregg Eure, MD,LAURENCE A. LEVINE, MD

March 7th 2021

Letter: BPH guidelines may ignore FDA, insurance criteria

ByGregg Eure, MD

May 12th 2020

"As we seek to understand MIST retreatment rates, as Houlihan and Köhler suggest, we must rely upon real-world population data," writes Gregg Eure, MD, in a letter to the editor.

Latest Updated Articles

Making Sense of the Reintervention Rate for BPH
Published: March 7th 2021 | Updated:
Letter: BPH guidelines may ignore FDA, insurance criteria
Published: May 12th 2020 | Updated:

Gregg Eure, MD

Articles by Gregg Eure, MD

Making Sense of the Reintervention Rate for BPH

Letter: BPH guidelines may ignore FDA, insurance criteria

Latest Updated Articles

Trending on Urology Times

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer